Lipid Nano-Crystal Platform

Improving the intracellular delivery of important therapeutics.

Our LNC platform enables safe, intracellular, and even orally-administered delivery of a broad range of drug therapies, including small molecules, drugs with blood level-limiting toxicities, nucleic acid polymers, proteins, peptides, vaccines, and gene editing technologies.

Based on our LNC technology, we have developed MAT2203 and MAT2501 – two potent treatments targeting life-threatening fungal and bacterial infections.